ATI RN
Atrium Health Womens Care Maternal Fetal Monitoring Questions
Question 1 of 5
The nurse’s role in diagnostic testing is to provide which of the following?
Correct Answer: B
Rationale: In the context of pharmacology and maternal fetal monitoring, the nurse plays a crucial role in providing information about diagnostic testing to the couple. Option B, "Information about the tests," is the correct answer because it aligns with the nurse's responsibility to educate patients on the purpose, procedure, risks, and benefits of diagnostic tests. Option A, "Advice to the couple," is incorrect because the nurse should not provide personal advice but rather evidence-based information to support the couple in making informed decisions. Option C, "Reassurance about fetal safety," while important, is not the primary role of the nurse in diagnostic testing. The nurse should provide information to empower the couple to make decisions based on knowledge. Option D, "Assistance with decision making," is partially correct but not as comprehensive as providing detailed information about the tests. Educationally, it is essential for nurses to understand their role in patient education and decision-making processes. By providing accurate and clear information, nurses can help patients make informed choices regarding their healthcare. This enhances patient autonomy, promotes shared decision-making, and ultimately improves patient outcomes. Nurses must be knowledgeable about diagnostic tests to effectively communicate with patients and support them in navigating the complexities of healthcare decisions.
Question 2 of 5
Which clinical conditions are associated with increased levels of alpha-fetoprotein (AFP)? (Select all that apply.)
Correct Answer: C
Rationale: The correct answer is C) Twin gestation. Elevated levels of alpha-fetoprotein (AFP) are associated with twin gestations due to the presence of multiple fetuses producing the protein. AFP is a protein produced by the fetal liver and yolk sac, and its levels can be elevated in the maternal serum and amniotic fluid in conditions like twin gestation. A) Down syndrome is not associated with increased levels of AFP. In fact, in Down syndrome, AFP levels are usually decreased. B) Molar pregnancy is also not directly associated with increased AFP levels. In molar pregnancies, abnormal trophoblastic tissue develops, but this condition does not lead to elevated AFP levels. D) Incorrect gestational age assessment of a normal fetus resulting in an earlier estimation is not a condition that directly leads to increased AFP levels. Gestational age errors may impact various pregnancy assessments but do not influence AFP levels. Educationally, understanding the factors influencing AFP levels is crucial for healthcare professionals involved in maternal-fetal care. This knowledge helps in interpreting screening tests accurately and in providing appropriate counseling and care to pregnant individuals. Understanding the specific conditions associated with elevated AFP levels can aid in the differential diagnosis of maternal-fetal conditions and guide further diagnostic and management decisions.
Question 3 of 5
A gravida, G1 P0000, is having her first prenatal physical examination. Which of the following assessments should the nurse inform the client that she will have that day? Select all that apply.
Correct Answer: A
Rationale: In this scenario, the correct assessment for the gravida having her first prenatal physical examination is A) Pap smear. The Pap smear is a crucial screening test to detect any abnormal cervical cells that could indicate cervical cancer or other issues. During the initial prenatal visit, it is important to assess the client's cervical health to ensure early detection and appropriate management if any abnormalities are found. B) Mammogram is not typically performed during the first prenatal visit. Mammograms are primarily recommended for women over 40 years of age as a screening tool for breast cancer. C) The glucose challenge test is usually performed later in pregnancy to screen for gestational diabetes, not during the initial prenatal visit for a gravida. D) The biophysical profile is a test performed later in pregnancy to assess the baby's well-being, usually starting around the third trimester. It includes ultrasound evaluation of fetal movements, muscle tone, breathing, amniotic fluid levels, and heart rate patterns. This assessment is not typically done during the first prenatal visit. Educationally, understanding the timing and purpose of specific assessments during prenatal care is vital for nurses and other healthcare providers to provide comprehensive and evidence-based care to pregnant clients. It ensures appropriate interventions, monitoring, and support throughout the pregnancy journey, promoting positive maternal and fetal outcomes.
Question 4 of 5
When assessing the psychological adjustment of an 8-week gravida, which of the following would the nurse expect to see signs of?
Correct Answer: A
Rationale: In the context of assessing the psychological adjustment of an 8-week gravida, the nurse would expect to see signs of ambivalence. Ambivalence refers to the conflicting feelings a woman may experience during pregnancy, such as mixed emotions about the pregnancy, concerns about the future, and uncertainties about motherhood. This is a common experience during the early stages of pregnancy as the woman adjusts to the changes happening in her life. Regarding the other options: - Depression (option B) may occur during pregnancy but is not typically a primary sign at 8 weeks unless there are pre-existing mental health issues. - Anxiety (option C) is common in pregnancy but may not be the primary expected sign at 8 weeks for all women. - Ecstasy (option D) is not a typical response to early pregnancy as it suggests extreme happiness which may not capture the range of emotions a woman may feel. Educationally, understanding the psychological aspects of pregnancy is crucial for nurses caring for pregnant women. By recognizing signs of ambivalence, nurses can provide appropriate support, education, and counseling to help women navigate their emotions and ensure a positive pregnancy experience. This knowledge enhances the nurse's ability to provide holistic care to pregnant women and promotes their overall well-being.
Question 5 of 5
The nurse working in an outpatient obstetric office assesses four primigravid clients. Which of the client findings should the nurse highlight for the physician? Select all that apply.
Correct Answer: A
Rationale: In this scenario, the correct answer is option A, which is "17 weeks’ gestation; denies feeling fetal movement." This finding should be highlighted to the physician because at 17 weeks of gestation, fetal movements should typically be felt by the mother. The absence of fetal movement at this stage could indicate a potential issue with fetal well-being, such as fetal distress or abnormal development, warranting further evaluation and monitoring. Option B, "24 weeks’ gestation; fundal height at the umbilicus," is not a concerning finding as fundal height corresponds to the gestational age and can vary among individuals. At 24 weeks, the fundal height at the umbilicus is within the expected range. Option C, "27 weeks’ gestation; salivates excessively," is not a typical indicator of a significant issue in pregnancy. While excessive salivation can be uncomfortable for the mother, it is not typically a cause for immediate concern unless it is accompanied by other symptoms. Option D, "34 weeks’ gestation; experiences uterine cramping," could indicate preterm labor, which is a serious concern in pregnancy. However, in this scenario, the absence of fetal movement at 17 weeks is a more urgent finding that requires immediate attention compared to uterine cramping at 34 weeks, which can be managed with appropriate interventions. Educationally, this question highlights the importance of assessing fetal movements as a crucial aspect of antenatal care. It underscores the significance of recognizing abnormal findings during pregnancy and the need for prompt communication with healthcare providers to ensure timely interventions and monitoring for maternal and fetal well-being.